US charges Tottenham owner Joe Lewis with insider trading
UK billionaire allegedly gave material non-public information about several companies to friends, his personal pilots, assistants, and romantic partners
Source: businesslive.co.za
📰 Solid Biosciences News
Page 8 - Solid Biosciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Solid Biosciences. Real-time updates on events, politics, business and more.
UK billionaire Joe Lewis appears in US court on insider trading charges
Financial Times: Lewis, whose family owns Tottenham Hotspur, accused of tip-offs.
Source: nzherald.co.nz
Tottenham Hotspur owner Joe Lewis puts up yacht to post bail
British Billionaire Joe Lewis is putting up his yacht to back a $300 million bond so he can walk free after he was arrested on insider trading charges.
Source: nypost.com
As Tottenham Hotspur boss Joe Lewis hands himself in to face charges of insider trading, TOM LEONARD asks - did the East End-born rags-to-riches billionaire give illegal share tips to friends, his personal pilots and even a beauty queen?
TOM LEONARD: Joe Lewis (pictured) is known as the silent owner of Tottenham Hotspur but, according to prosecutors, that may be the only area of business where he keeps his mouth shut.
Source: dailymail.co.uk
Solid Biosciences (NASDAQ:SLDB) Shares Down 4.6%
Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report)’s stock price fell 4.6% during mid-day trading on Monday . The stock traded as low as $4.43 and last traded at $4.52. 10,409 shares were traded during mid-day trading, a decline of 66% from the average session volume of 30,468 shares. The stock had previously closed at […]
United States Prudential Financial Inc Asset Management Inc Solid Biosciences Inc Mirabella Financial Services Atria Wealth Solutions Inc
Source: wkrb13.com
Duchenne Muscular Dystrophy Global Market Report 2023
Major players in the duchenne muscular dystrophy market are Bristol Myers Squibb Company, FibroGen Inc., Italfarmaco SpA, NS Pharma Inc., Pfizer Inc., PTC...
Source: globenewswire.com
Ultragenyx's manufacturing facility, Massachusetts, USA
Ultragenyx Pharmaceutical opened its first large-scale gene therapy manufacturing facility in Bedford, Massachusetts, in June 2023.
United Kingdom Commonwealth Of Massachusetts United States Daiichi Sankyo Ultragenyx Hela Cardinal Group
Source: pharmaceutical-technology.com
Curing the incurable: FDA makes history, approves Elevidys to treat pediatric Duchenne muscular dystrophy
The U.S. Food and Drug Administration approved Elevidys in June, making it the first gene therapy designed to treat pediatric Duchenne muscular dystrophy, a life-threatening genetic disorder of progressive muscular weakness.
United States Drug Administration Sarepta Therapeutics Solid Biosciences Jerry Mendell Nationwide Children
Source: dailynexus.com
Cell And Gene Therapies Face Manufacturing Capacity Constraints
The increasing numbers of cell and gene therapy pipeline candidates, along with a steady growth of new approvals, are stretching manufacturing capacity to its limits.
Source: forbes.com